CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. [electronic resource]
Producer: 20160606Description: 152-8 p. digitalISSN:- 1879-0887
- Aged
- Biomarkers, Tumor -- metabolism
- Chemoradiotherapy, Adjuvant -- methods
- Disease-Free Survival
- Esophageal Neoplasms -- diagnosis
- Female
- Hedgehog Proteins -- metabolism
- Humans
- Hyaluronan Receptors -- metabolism
- Male
- Middle Aged
- Neoadjuvant Therapy -- methods
- Neoplasm Proteins -- metabolism
- Prognosis
- Retrospective Studies
- SOXB1 Transcription Factors -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.